Skip to content

The effect of vibration therapy on diabetes

The effect of lower limb vibration therapy on neuropathic pain in diabetic patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2012062310076N2
Enrollment
36
Registered
2012-09-16
Start date
2012-02-20
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetic neuropathy. With neurological complication

Interventions

vibrattion therapy.
vibrattion therapy

Sponsors

Arak University of Medical Sciences,Vice Chancellor for Research
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: diagnosis of diabetic neuropathy in the lower extremities, according to a rating system based on clinical symptoms and examination (by a physician, neurologist); no history of any of Vibration Therapy; no receive pain medication or drugs affecting Vibration Therapy; lack of neurological diseases such as stroke, as well as any conditions that may impact on neuropathy (multiple sclerosis, gout, Parkinson's, spinal cord injury, Barre, rheumatic disease), and this is confirmed by a doctor, a neurologist; proven having mental illness (with doctor's approval citing cases) and minimum score of 1 neuropathic pain according to VAS scale. Exclusion criterion: patients who are unable to work due to the project intervention.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Pain. Timepoint: Before intervention, one week after intervention, 2week after intervention and 3 days after the end of intervention. Method of measurement: Visual analogous scale scale.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactRezvan Ghafarzadegan

Arak University of Medical Sciences

rghafarzadegan@gmail.com+98 86 1367 1144

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026